A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT). (2018)
Attributed to:
Cutaneous Immunology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjd.16717
PubMed Identifier: 29727479
Publication URI: http://europepmc.org/abstract/MED/29727479
Type: Journal Article/Review
Volume: 179
Parent Publication: The British journal of dermatology
Issue: 6
ISSN: 0007-0963